An integrated strategy for the discovery of drug targets by the analysis of protein-protein interactions

被引：3

作者：

Peltier, JM ^{[1
]}

Askovic, S ^{[1
]}

Becklin, RR ^{[1
]}

Chepanoske, CL ^{[1
]}

Ho, YSJ ^{[1
]}

Kery, V ^{[1
]}

Lai, SP ^{[1
]}

Mujtaba, T ^{[1
]}

Pyne, M ^{[1
]}

Robbins, PB ^{[1
]}

von Rechenberg, M ^{[1
]}

Richardson, B ^{[1
]}

Savage, J ^{[1
]}

Sheffield, P ^{[1
]}

Thompson, S ^{[1
]}

Weir, L ^{[1
]}

Widjaja, K ^{[1
]}

Xu, NF ^{[1
]}

Zhen, YJ ^{[1
]}

Boniface, JJ ^{[1
]}

机构：

[1] Prolexys Pharmaceut Inc, Salt Lake City, UT 84116 USA

来源：

INTERNATIONAL JOURNAL OF MASS SPECTROMETRY | 2004年 / 238卷 / 02期

关键词：

protein interactions; MS/MS; affinity tags; drug discovery; drug targets;

D O I：

10.1016/j.ijms.2003.12.039

中图分类号：

O64 [物理化学（理论化学）、化学物理学]; O56 [分子物理学、原子物理学];

学科分类号：

070203 ; 070304 ; 081704 ; 1406 ;

摘要：

Proteomics-based technologies have the potential to accelerate the development of drugs, but such technologies must be well integrated in order to have a positive impact. We describe, herein, a multi-step process for the discovery of protein-protein interactions. It is shown that process stages are interdependent and can influence, either positively or negatively, subsequent steps. Optimization of each step, in the context of the full process, is essential for the overall success of the experiment. (C) 2004 Elsevier B.V. All rights reserved.

引用

页码：119 / 130

页数：12

共 50 条

[41] Inducing protein-protein interactions with molecular glues
Che, Ye
Gilbert, Adam M.
Shanmugasundaram, Veerabahu
Noe, Mark C.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (15) : 2585 - 2592
[42] Noncellular screening for the discovery of protein-protein interaction modulators
Kieffer, Charline
Jourdan, Jean Pierre
Jouanne, Marie
Voisin-Chiret, Anne Sophie
DRUG DISCOVERY TODAY, 2020, 25 (09) : 1592 - 1603
[43] Developing a machine learning model to identify protein-protein interaction hotspots to facilitate drug discovery
Nandakumar, Rohit
Dinu, Valentin
PEERJ, 2020, 8
[44] Protein-fragment complementation assays for large-scale analysis of protein-protein interactions
Blaszczak, Ewa
Lazarewicz, Natalia
Sudevan, Aswani
Wysocki, Robert
Rabut, Gwenael
BIOCHEMICAL SOCIETY TRANSACTIONS, 2021, 49 (03) : 1337 - 1348
[45] NMR fragment screening: Tackling protein-protein interaction targets
Schade, M
Oschkinat, H
CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (03) : 365 - 373
[46] The future of G protein-coupled receptors as targets in drug discovery
Lundstrom, K
IDRUGS, 2005, 8 (11) : 909 - 913
[47] Query-guided protein-protein interaction inhibitor discovery
Celis, Sergio
Hobor, Fruzsina
James, Thomas
Bartlett, Gail J.
Ibarra, Amaurys A.
Shoemark, Deborah K.
Hegedus, Zsofia
Hetherington, Kristina
Woolfson, Derek N.
Sessions, Richard B.
Edwards, Thomas A.
Andrews, David M.
Nelson, Adam
Wilson, Andrew J.
CHEMICAL SCIENCE, 2021, 12 (13) : 4753 - 4762
[48] Peptidomimetics Targeting Protein-Protein Interactions for Therapeutic Development
Zhang, Gan
Andersen, Jessica
Gerona-Navarro, Guillermo
PROTEIN AND PEPTIDE LETTERS, 2018, 25 (12) : 1076 - 1089
[49] Targeting of extracellular protein-protein interactions with macrocyclic peptides
Taguchi, Shota
Suga, Hiroaki
CURRENT OPINION IN CHEMICAL BIOLOGY, 2021, 62 : 82 - 89
[50] Stabilizer-Guided Inhibition of Protein-Protein Interactions
Milroy, Lech-Gustav
Bartel, Maria
Henen, Morkos A.
Leysen, Seppe
Adriaans, Joris M. C.
Brunsveld, Luc
Landrieu, Isabelle
Ottmann, Christian
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (52) : 15720 - 15724

← 1 2 3 4 5 →